Ensign Peak Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-89,185
| Closed | -$1.94M | – | 1752 |
|
|
2023
Q4 | $1.94M | Hold |
89,185
| – | – | ﹤0.01% | 924 |
|
|
2023
Q3 | $1.37M | Hold |
89,185
| – | – | ﹤0.01% | 986 |
|
|
2023
Q2 | $2.12M | Hold |
89,185
| – | – | ﹤0.01% | 856 |
|
|
2023
Q1 | $2.27M | Hold |
89,185
| – | – | ﹤0.01% | 799 |
|
|
2022
Q4 | $2.61M | Sell |
89,185
-6,590
| -7% | -$192K | 0.01% | 733 |
|
|
2022
Q3 | $1.96M | Buy |
95,775
+74,370
| +347% | +$1.53M | ﹤0.01% | 789 |
|
|
2022
Q2 | $248K | Hold |
21,405
| – | – | ﹤0.01% | 1732 |
|
|
2022
Q1 | $396K | Buy |
+21,405
| New | +$396K | ﹤0.01% | 1656 |
|